Zuko

Founder of Z Transportation Inc

[Zuko @zukomk]

@elonmusk I will say former and FUTURE Trillionaire

[Drive For Z Transportation @DriveForZ]

Today, we proudly celebrate Susan, Sam, and Ivana for reaching 10 incredible years with Z Transportation! 📷
Do you know who’s helping you behind the scenes while you’re out on the road?

[Drive For Z Transportation @DriveForZ]

Two million safe miles. Fifteen years of loyalty. One incredible journey.

Congratulations to Zoltan Korpa on becoming a Platinum Driver at Z Transportation! His professionalism, commitment, and dedication to safety have earned him a $10,000 award and a brand-new Volvo VNL 640.

[Mercedes-AMG PETRONAS F1 Team @MercedesAMGF1]

Victory in Spa for Kimi! 🏆

[Shankar Musunuri @drsmusunuri]

I'm excited to share this announcement and what it means for Ocugen's next chapter. Partnerships like this help us broaden our global reach, bring us closer to patients, and continue creating long-term value. #GlobalImpact #Biotech

[Rekt Capital @rektcapital]

#BTC

Bitcoin Bear Market Progress:

▓▓▓▓▓▓▓░░░ 74.0%

$BTC #Crypto #Bitcoin

[Ocugen @Ocugen]

Understanding the retina is an important step in vision health. Many #retinaldiseases are linked to genetic mutations that can lead to vision loss. #Ocugen is advancing modifier gene therapies designed to address the causes of these rare conditions and help preserve vision.

[Ocugen @Ocugen]

“I have more adaptation to light and darkness.” – Nancy

After living with #retinitispigmentosa for 31 years, Nancy shares her story and hope for the future after participating in Ocugen’s #OCU400 clinical trial. #Ocugen $OCGN

Learn more about OCU400: https://t.co/OXzETxjDpJ

[Ocugen @Ocugen]

What makes #OCU400 different?

OCU400 is designed to address multiple RP mutations through a potential one-time therapy.

Follow us for updates as we advance OCU400 toward a planned BLA submission this year.

#RetinitisPigmentosa #GeneTherapy $OCGN

[Ocugen @Ocugen]

Early #OCU410ST results show:
✓ 54% reduction in atrophic lesion growth
✓ 100% of treated eyes stabilized or improved
✓ +6 letter gain in visual acuity

Hear from an OCU410ST clinical trial participant: https://t.co/znh5I8UL9R

$OCGN

[Ocugen @Ocugen]

Ocugen is excited to showcase our innovative modifier #genetherapy platform for inherited retinal and blindness diseases at three conferences this month. @IAmBiotech @NobleCapMkts $OCGN #InvestorRelations

🔗https://t.co/ok0itKrdvM
Noble Capital replay: https://t.co/zLQlXmzENU

[Supplements Manufacturer @MoreFlax]

$OCGN #OCUGEN 👇 👇 👇
Read between the lines.... @NeenaHaider 👏👏👏🙏🙏🙏 @Ocugen

[Ocugen @Ocugen]

What is #Stargardtdisease?

A rare inherited retinal disease that can cause central vision loss, often beginning early in life. Ocugen’s investigational #genetherapy candidate, #OCU410ST, is designed to target disease pathways. #Biotech $OCGN

[Ocugen @Ocugen]

Momentum continues at Ocugen. With $130 million in financing secured, we are well-positioned to advance our three late-stage
programs as we work toward filing three BLAs by 2028.

Learn more: https://t.co/7nSj5EJkPZ

#GeneTherapy #Biotech #FinancialUpdate $OCGN

[Ocugen @Ocugen]

During #ARVO2026, Ocugen shared a poster presentation on reducing variability in quantitative autofluorescence measurements through automation for #geographicatrophy & #Stargardtdisease. Proud to support innovation advancing research for blindness diseases. $OCGN #AMD @ARVOinfo

[Supplements Manufacturer @MoreFlax]

$OCGN #OCUGEN 👇 👇 👇

Oppenheimer 💥💥💥
That is huge !!!

https://t.co/C8VYI2ZSew

[Shankar Musunuri @drsmusunuri]

Encouraging to see continued progress across our pipeline and operations this quarter. With key milestones achieved and a strong balance sheet, we are well positioned as we advance toward the next phase of development and potential filings.

#GeneTherapy #Biotech

[Ocugen @Ocugen]

Don’t miss it. Ocugen will host a live webcast on May 5 at 8:30 a.m. EDT to share 1Q 2026 results and key updates, including progress toward key catalysts in 2026. #QuarterlyUpdate #Biotech $OCGN

Details: https://t.co/jxFgC7VQ7K
Replay: https://t.co/yvCUC9lLm8

[Billythekid123 @B1llyTh2K3d]

Show them @Ocugen @drsmusunuri $OCGN

Give this post a like, a share, a quote. Bookmark it. Spread it far and wide.

If you’re holding strong and have been for some time now, show them that you’re part of the movement.

Show them that we’ve only grown over time. Alive and well.

[Shankar Musunuri @drsmusunuri]

Great to connect with the U.S. @CommerceGov Certified Trade Mission to Singapore with https://t.co/81gT4sERjh. Excited to build on these conversations and strengthen global collaboration.